XML 48 R28.htm IDEA: XBRL DOCUMENT v2.4.0.6
Acquisitions (Tables)
12 Months Ended
Jun. 30, 2012
Algol Europe GmbH [Member]
 
Business Acquisition [Line Items]  
Acquisition Related Purchase Price Allocation
The purchase price, identified intangibles and goodwill as of the acquisition date were as follows:
 
Purchase
Price
 
Goodwill
 
Identifiable
Intangible
Assets
 
(in thousands)
Algol Europe, GmbH
$
9,965

 
$
712

 
$
2,287

CDC Brasil S A [Member]
 
Business Acquisition [Line Items]  
Acquisition Related Purchase Price Allocation
These adjustments are summarized in the following table:
 
As of April 15, 2011
 
Preliminary Purchase Allocation
 
Purchase Accounting Adjustments
 
Revised Purchase Allocation
Consideration
(in thousands)
Initial cash payment, net of cash acquired
$
36,228

 
$

 
$
36,228

Fair value of earnout obligation
23,952

 

 
23,952

Total consideration
60,180

 

 
60,180

Recognized amounts of identifiable assets acquired and liabilities assumed
 
 
 
 
 
Accounts receivable, net of allowance
21,378

 

 
21,378

Inventories
30,560

 

 
30,560

Prepaid expenses and other assets
3,575

 

 
3,575

Current deferred income taxes, net
1,409

 
(3,225
)
 
(1,816
)
Property and equipment, net
1,741

 

 
1,741

Intangible assets
18,327

 
4,278

 
22,605

Escrowed pre-acquisition contingencies receivable
16,013

 
7,977

 
23,990

Short-term borrowings
(1,277
)
 

 
(1,277
)
Accounts payable
(34,006
)
 

 
(34,006
)
Accrued expenses and other liabilities
(3,896
)
 

 
(3,896
)
Income taxes payable
(2,097
)
 
1,174

 
(923
)
Escrowed pre-acquisition contingencies payable
(16,013
)
 
(7,977
)
 
(23,990
)
Long-term deferred income taxes, net

 
(3,141
)
 
(3,141
)
Other long-term liabilities
(177
)
 

 
(177
)
Total identifiable net assets
35,537

 
(914
)
 
34,623

Goodwill
$
24,643

 
$
914

 
$
25,557

Identified Intangible Assets
The revised purchase price allocated to the fair value of identified intangible assets associated with the acquisition of CDC after the finalization of purchase accounting is as follows:
 
Amount
Identified intangible assets
(in thousands)
Trade names (2 year useful life)
$
2,746

Customer relationships (6 year useful life)
18,965

Non-compete agreements (5 year useful life)
894

Total identified intangible assets
$
22,605

Impact Of Incremental Amortization And Related Tax Effect
The impact of the incremental amortization and related income tax effect recorded in the third quarter of this fiscal year is summarized in the following table:
 
June 30, 2012
 
(in thousands)
Consolidated income statement
 
Amortization expense
$
441

Provision for income taxes
$
(150
)
Business Acquisition, Pre-acquisition Contingencies and Related Indemnification Receivables
The table below summarizes the balances and line item presentation of these pre-acquisition contingencies and corresponding indemnification receivables in the Company's consolidated balance sheet:
 
June 30, 2012
June 30, 2011
April 15, 2011
 
(in thousands)
Assets
 
 
 
Prepaid expenses and other assets (current)
$
3,886

$

$

Other assets (noncurrent)
$
5,112

$
16,250

$
16,013

Liabilities
 
 
 
Other current liabilities
$
3,886

$

$

Other long-term liabilities
$
5,112

$
16,250

$
16,013

Supplemental Pro Forma Information
The following unaudited pro forma summary presents consolidated information of the Company as if the business combination had occurred on July 1, 2009, based on the final purchase price allocation as adjusted in fiscal 2012 for the additional purchase price allocated to CDC's customer relationships:
 
June 30,
 
2011
 
2010
Unaudited, Supplemental Pro Forma Information
(in thousand, except
per share information)
Net sales
$
2,786,905

 
$
2,247,721

Net income
$
75,328

 
$
52,450

Diluted earnings per share
$
2.76

 
$
1.95